Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
None listed
Sponsors
IndoUS Science and Technology Forum IUSSTF
Eligibility
Inclusion criteria
Inclusion criteria: In the inclusion criteria, both asymptomatic and symptomatic patients (mild, moderate, severe and critical) will be evaluated for identification of biomarkers
Exclusion criteria
Exclusion criteria: Patients who comes below 15 years and above 70 years will be excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Establishing the relationship between the host response severity and bio-molecular factors (exposome, proteome, immunity factors) in patients infected with SARS-Cov2. This will help in the identification of a set of biomarkers which are found in the symptomatic and asymptomatic subjects for the prognostication of different stages of the diseaseTimepoint: October 2021 | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate Biochemical, genetic factors and proteomic markers to quantify the nature of patient response to COVID infection and strive to develop a response severity score including these markers.Timepoint: April 2022 | — |
Countries
India
Contacts
Public ContactDr Shantikumar V Nair
Amrita Centre for Nanosciences and Molecular Medicine, Amrita Institute of Medical Sciences
Outcome results
None listed